The FDA approved a rechargeable neurostimulator that features a sensing-enabled DBS system for personalized treatment of movement disorders such as Parkinson disease, essential tremor, dystonia, and epilepsy.
The FDA approved a rechargeable neurostimulator that features a sensing-enabled DBS system for personalized treatment of movement disorders such as Parkinson disease, essential tremor, dystonia, and epilepsy.
The FDA approved a rechargeable...